Izafe Group
0.2
SEK
+5.26 %
IZAFE B
First North Stockholm
Medical Equipment & Services
Health Care
Be the first to follow this company
+5.26%
+8.7%
-1.96%
0%
-8.68%
-30.56%
-48.72%
-84.03%
-90.4%
-94.24%
izafe.se/investor-relations
iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions. The company offers products such as Dosell, a pharmaceutical robot, and the SaaS solution Pilloxa, a connected dose bag. The products aim to reduce the risk of incorrect medication. The customers are private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group has its headquarters in Stockholm.
Revenue
1.82M
EBIT %
-1,958.24 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
IZAFE B
Daily low / high price
0.198 / 0.2
SEK
Market cap
55.12M SEK
Turnover
290.8K SEK
Volume
1.5M
Financial calendar
Annual report
2025-02-14
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Gästrike Nord Invest AB | 21.8 % | 21.4 % |
| Stefan Wård | 11.0 % | 10.8 % |
| Nordnet Pension | 5.7 % | 5.6 % |
| Junior Farma SL | 4.8 % | 4.7 % |
| Francesco Mazzotta | 3.7 % | 3.6 % |
| Helena Rönnqvist | 3.7 % | 3.6 % |
| Hovgården Invest AB | 3.7 % | 3.6 % |
| Avanza Pension | 2.5 % | 2.5 % |
| Eva Redhe | 2.5 % | 2.5 % |
| K4 Gruppen Aktiebolag | 2.4 % | 2.4 % |
ShowingAll content types
Dosell säkrar stor order på 1 000 Dosell till Nederländerna – Ett ordervärde på 3 000 TSEK och upp till 400 TSEK/mån i återkommande intäkter
Dosell Secures Large Order for 1,000 Units in the Netherlands – Order Value of SEK 3 Million and Up to SEK 400,000/Month in Recurring Revenue
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools